Roche Holding (QX) (USOTC:RHHBY)
Historical Stock Chart
2 Months : From Nov 2019 to Jan 2020
By Stephen Nakrosis
The U.S. Food and Drug Administration said Thursday it authorized the marketing of Roche Molecular Systems Inc.'s diagnostic test to detect Methicillin-resistant Staphylococcus aureus, or MRSA, bacteria.
The FDA said the test "may allow health care professionals to evaluate patients for colonization with MRSA bacteria more quickly than traditional culture-based techniques."
The new test can detect the presence of MRSA from a nasal swab in as little as five hours, the FDA said, compared to the 24 to 48 hours a conventional diagnosis may take.
Roche Molecular Systems is part of Roche Holding AG.
--Write to Stephen Nakrosis at email@example.com
(END) Dow Jones Newswires
December 05, 2019 12:55 ET (17:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.